title: Immunosuppression withdrawal after liver transplantation: what are the next steps?
abstract: Achieving operational tolerance after liver transplantation remains a challenge for clinicians and scientists. Prospective immunosuppression withdrawal trials coupled with biomarker development and histologic assessment will be critical to the increasing applicability of drug-free transplantation from a sporadic event to a safely achieved, predictable state for increasing numbers of patients.
authors.affiliation: Children's Hospital of Pittsburgh (CHP) Hillman Center for Pediatric Transplantation, Pittsburgh, PA 15224, USA. george.mazariegos@chp.edu
authors.forename: George V
authors.initials: GV
authors.lastname: Mazariegos
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016031:Liver Transplantation / Q000401:mortality; D023001:Transplantation Tolerance
chemical_list: D007166:Immunosuppressive Agents